Advanced search×

Identification of the Geobacter metallireducens bamVW two-component system, involved in transcriptional regulation of aromatic degradation.

Appl Environ Microbiol 76(1):383-5 (2010) PMID 19915033

Regulation of aromatic degradation in obligate anaerobes was studied in the Fe(III)-respiring model organism Geobacter metallireducens GS-15. A two-component system and a sigma54-dependent promoter were identified that are both involved in the regulation of the gene coding for benzoate-coenzyme A ligase, catalyzing the initial step of benzoate degradation.

DOI: 10.1128/AEM.02255-09
Version: za2963e q8za5 q8zbc q8zcf q8zd6 q8zed q8zf5 q8zg7

Similar articles you may find interesting…

  1. Protocol: does sodium nitrite administration reduce ischaemia-reperfusion injury in patients presenting with acute ST segment elevation myoc...

    J Transl Med 11(1):116 (2013) PMID 23648219

    We investigate whether intravenous sodium nitrite administration immediately prior to percutaneous coronary intervention (PCI) in patients with acute ST segment elevation myocardial infarction will reduce myocardial infarct size. This is a phase II, randomised, placebo-controlled, double-blinded and...
  2. Application of endotoxin and cytokine adsorption haemofilter in septic acute kidney injury due to Gram-negative bacterial infection.

    Hong Kong Med J (2013) PMID 23650198

    OBJECTIVE. Endotoxins and cytokines play an important role in the pathogenesis of multi-organ failure and mortality in patients suffering from severe Gram-negative bacterial infection. The aim of this study was to determine whether in patients with such infections, use of a haemofilt...
  3. Three feasible strategies to minimize kidney injury in 'incipient AKI'

    Nat Rev Nephrol (2013) PMID 23649020

    We propose three strategies to preserve kidney function and minimize further kidney injury in patients with 'incipient AKI'. These include-when appropriate for the prevailing cause of 'incipient AKI'-use of low-chloride-containing intravenous solutions, continued use of renin-angiotensin system anta...